Skip to main content
Premium Trial:

Request an Annual Quote

GCI Licenses GeneticXchange K1 Data Integration Platform

NEW YORK, Feb. 12-Genomics Collaborative Inc. has licensed GeneticXchange's K1 middleware data integration platform for its Tantalus database, the software company said today.

 

GCI's Tantalus database is designed to integrate clinical data with genomic information and data from scientific literature.

 

The GeneticXchange K1 system is specially constructed for bioinformaticists and genomic researchers, allowing users to design their own modifications and improvements to the system.

 

This middleware platform makes GCI's database easier to build and maintain, makes production software simpler to create and ultimately speeds information access, said a company representative in a statement. The system's drivers also allow real-time access to public databases.

 

Last March, the two companies inked a five-year development deal to integrate R&D. Through that partnership, GeneticXchange provides data integration software to GCI, and GCI execs help direct software development at GeneticXchange.

 

GCI maintains a large database that cross-links samples of DNA, tissue, and sera with patient data. The Cambridge, Mass.-based company also does drug discovery for cardiovascular and inflammatory diseases.

 

Menlo Park, Calif.-based GeneticXchange has also licensed this system to the Genome Institute of Singapore.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.